11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Autor:	Rinne, Juha O1 juha.rinne@tyks.fi, Brooks, David J2, Rossor, Martin N3, Fox, Nick C3, Bullock, Roger4, Klunk, William E5, Mathis, Chester A5, Blennow, Kaj6, Barakos, Jerome7, Okello, Aren A2, de LIano, Sofia Rodriguez Martinez2, Liu, Enchi8, Koller, Martin9, Gregg, Keith M8, Schenk, Dale9, Black, Ronald10, Grundman, Michael9, Gandy, Sam (AUTHOR)
Zdroj:	Lancet Neurology. Apr2010, Vol. 9 Issue 4, p363-372. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu